Monday, August 12, 2019

Plant Based Product News: Reviv3 Procare (OTCQB: $RVIV) Appoints Gerry Udell, Inc. as Manufacturer's Rep for Thirteen States; @ReviveProcare


Plant Based Product News: Reviv3 Procare (OTCQB: $RVIV) Appoints Gerry Udell, Inc. as Manufacturer's Rep for Thirteen States; @ReviveProcare

LOS ANGELES, Calif., August 12, 2019 (Investorideas.com Newswire) – Reviv3 Procare Company (OTCQB: RVIV), a manufacturer of plant-based salon products designed for modern hair care challenges announced today it appointed Gerry Udell, Inc., as representatives of its professional salon products for the states of Connecticut, Delaware, Dist. Of Columbia, Maine, Pennsylvania, Massachusetts, New Hampshire, New Jersey, New York, Rhode Island, Vermont, West Virginia and Maryland.

“Gerry Udell is a highly respected manufacturer’s rep organization with a reputation of excellence in the professional beauty space. We believe this partnership will significantly expand our market exposure and strengthen our position in the northeast territories.” Said Donald Starace, President of Reviv3.

Gerry Udell Inc., is the largest regional sales agency in the Professional Beauty industry. The family owned company has been in business for fifty-eight years. Gary Udell, President of Gerry Udell stated “Our company feels that the Reviv3 hair treatment system has already been tested and proven to be effective in the prevention of hair loss. We believe there is a great opportunity in this category in the Professional Beauty field.” According to Udell, the company has already targeted prospective distributorships that will be able to promote and expand the line to leading salons and spas. Udell stated “Our entire organization believes Reviv3 Procare will become a major brand in the Professional Beauty industry.

Reviv3 salon products were initially launched in exclusive salons in Italy and New York. The products include a line of hair cleansing, moisturizing, thickening agents, restoratives and environmental defense products that address the hair care challenges of the human body in transition. The company is committed to the cause of thinning hair by restoring the strength, protein and critical moisture that is degraded over time.

About Reviv3 Procare Company
Reviv3 Procare Company is engaged in the manufacturing, marketing, sale and distribution of premium quality hair and skin care products under various trademarks and brands. We are committed to using the highest quality active ingredients found in nature to create professional grade products that simply work. Our products are sold in targeted markets in United States, Canada, Europe, and Asia.

Forward-Looking Statements
This press release contains a number of forward-looking statements within the meaning of the federal securities laws. The use of words such as “anticipates,” “expects,” “intends,” “plans,” “confident that” and “believes,” among others, generally identify forward-looking statements.
These forward-looking statements are based on currently available information, and management’s belief, projections, and current expectations subject to a number of significant risks and uncertainties. Factors that could cause actual results to differ materially from those in the forward-looking statements include, among other things: (i) Reviv3’s ability to grow net sales and adjusted EBITDA as anticipated; (ii) our ability to fund our operating expenses (iii) potential difficulties or delays Reviv3 may experience in implementing its cost savings and efficiency initiatives; (iv) Reviv3’s ability to compete effectively with other hair and skin care companies (v) the concentration of Reviv3’s customers, potentially increasing the negative impact to Reviv3 by changing purchasing or selling patterns (vi) changes in laws or regulations in the United States and/or in other major markets, such as China, in which Reviv3 operates, including, without limitation, with respect to taxes, tariffs, trade policies or product safety, which may increase Reviv3’s product costs and other costs of doing business, and reduce Reviv3’s earnings. Potential investors are urged to consider these factors carefully in evaluating the forward-looking statements. These forward-looking statements speak only as of the date hereof. Except as required by law, Reviv3 does not assume any obligation to update or revise these forward-looking statements for any reason, even if new information becomes available in the future.

This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release on the Investorideas.com newswire https://www.investorideas.com/News-Upload/
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.


No comments: